Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus

Journal of Dermatological Treatment

Volumn 12, Issue 3, 2001, Pages 145-147

  Thomson, K F ^a   Goodfield, M J D ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Cutaneous; DLE; Low dose; Lupus; SLE; Thalidomide

Indexed keywords

AURANOFIN; CHLOROQUINE; DAPSONE; GOLD; HYDROXYCHLOROQUINE; MEPACRINE; METHOTREXATE; THALIDOMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; MALE; NAUSEA; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REMISSION; SEDATION; SKIN INFLAMMATION; SKIN LUPUS ERYTHEMATOSUS; TERATOGENICITY; TREMOR; VERTIGO;

ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THALIDOMIDE;

EID: 0035204387     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630152607871     Document Type: Article

References (9)

1. Rediscovering thalidomide: A review of its mechanism of action, side-effects, and potential uses
2. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus
3. Thalidomide in the cutaneous manifestations of lupus erythematosus experience in sixteen consecutive patients
4. American experience with low dose thalidomide therapy for severe cutaneous lupus erythematosus
5. Thalidomide treatment of subacute cutaneous lupus erythematosus
6. Thalidomide in the treatment of chronic discoid lupus erythematosus
7. Chronic cutaneous lupus erythematosus: Thalidomide treatment of 11 patients
8. Thalidomide therapy for inflammatory dermatoses
9. Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide